Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Friday broker round-up

Fri, 05th Apr 2019 12:53

(Sharecast News) - Purplebricks: Berenberg downgrades to sell with a target price of 80p.Countrywide: Berenberg upgrades to buy with a target price of 10p.Foxtons: Berenberg upgrades to hold with a target price of 60p.LSL Property Services: Berenberg reiterates hold with a target price of 250p.Restaurant Group: Berenberg reiterates buy with a target price of 175p.Astrazeneca: Deutsche Bank reiterates buy with a target price of 6,900p.Glaxosmithkline: Deutsche Bank reiterates hold with a target price of 1,520p.Vodafone: Barclays reiterates overweight with a target price of 200p.Pennon: Barclays reiterates equal weight with a target price of 830p.Smart Metering System: Barclays reiterates equal weight with a target price of 2,320p.Dunelm: Peel Hunt downgrades to add with a target price of 1,000p.Safestyle: Liberum reiterates buy with a target price of 110p.Motorpoint: Liberum reiterates buy with a target price of 277p.ASOS: Shore Capital Markets reiterates hold.easyJet: Canaccord reiterates hold with a target price of 1,080p.Stagecoach: Jefferies downgrades to underperform with a target price of 160p.PaddyPower Betfair: Berenberg reiterates hold with a target price of 6,500p.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.